Sesen Bio Inc reports results for the quarter ended in September - Earnings Summary

Carisma Therapeutics

07/11/2022 14:01

* Sesen Bio Inc  SESN.OQ  reported quarterly adjusted
earnings of
10 cents​​ per share for the quarter ended in September. The
lone analyst forecast for the quarter was for a loss of 8 cents
per share.
    * Revenue was $40.00 million​; analysts expected zero. 
    * Sesen Bio Inc's reported EPS for the quarter was 10
cents​.
    * The mean earnings estimate of analysts had risen by
about 33.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Sesen Bio Inc shares had risen by 27.5% this quarter and
lost 33.5% so far this year.
    * The company reported quarterly net income of $20.44
million.
    * Wall Street's median 12-month price target for Sesen Bio
Inc is
$0.80 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
7 at 02:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.08          0.10           Beat
 Jun. 30 2022      -0.13          -0.16          Missed
 Mar. 31 2022      -0.10          0.00           Beat
 Dec. 31 2021      -0.07          0.04           Beat